
Overview
Constantine Stratakis is a Medical Genetics specialist and a Gastroenterologist in Bethesda, Maryland. Dr. Stratakis has been practicing medicine for over 31 years and is rated as an Advanced provider by MediFind in the treatment of Ornithine Transcarbamylase Deficiency. His top areas of expertise are Cushing's disease, Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, Orchiectomy, and Hormone Replacement Therapy (HRT).
His clinical research consists of co-authoring 521 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Ornithine Transcarbamylase Deficiency.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Rubenstein Child Health Building
Dr. Ada Hamosh is the Dr. Frank V. Sutland Professor of Pediatric Genetics in the Departments of Genetic Medicine and Pediatrics. Since 2002, she has served as clinical director of the McKusick-Nathans Institute of Genetic Medicine, now Department of Genetic Medicine and scientific director of the Online Mendelian Inheritance in Man® (OMIM), a catalog of more than 16,800 human genes and genetic disorders created by Dr. Victor A. McKusick. Her research centers the molecular basis of Mendelian disorders, the integration of genetics into clinical practice and the diagnosis and management of inborn errors of metabolism. Dr. Hamosh earned a bachelor’s degree in biology from Wesleyan University, a medical degree from Georgetown University School of Medicine and a master’s of public health from Johns Hopkins University School of Public Health. She later completed a fellowship in medical and biochemical genetics from the Johns Hopkins School of Medicine, before joining the Johns Hopkins faculty in 1992. Dr. Hamosh began her genetics career focusing on cystic fibrosis, serving as coordinator of the International Cystic Fibrosis Genotype-Phenotype Consortium. She served as chair of the Maryland State Advisory Council for Hereditary & Congenital Disorders from 2001-2009, during which time she also served on the executive committee of the Genetic Counseling Training Program, run by Johns Hopkins University and the National Human Genome Research Institute. Dr. Hamosh has authored more than 128 publications on a variety of topics. In addition, she is a member of 16 professional associations and advisory committees including the American Society of Human Genetics, the Steering Committee of the Global Alliance for Genomics and Health, and the executive board of the Human Genome Organization, of which she will be President from 2023-2025. Dr. Hamosh was recognized in Baltimore magazine as one of the region’s top doctors in 2013, and 2016-2020. Dr. Hamosh is rated as a Distinguished provider by MediFind in the treatment of Ornithine Transcarbamylase Deficiency. Her top areas of expertise are Methylmalonic Acidemia, Maple Syrup Urine Disease, Ornithine Transcarbamylase Deficiency, Phenylketonuria (PKU), and Deep Brain Stimulation.
Peter Mcguire is a Medical Genetics specialist and a Pediatrics provider in Bethesda, Maryland. Dr. Mcguire is rated as an Advanced provider by MediFind in the treatment of Ornithine Transcarbamylase Deficiency. His top areas of expertise are Ornithine Transcarbamylase Deficiency, Urea Cycle Disorders (UCD), Coenzyme Q Cytochrome C Reductase Deficiency, and Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency.
Rubenstein Child Health Building
Dr. Hilary Vernon is a Professor of Genetic Medicine and pediatrics at the Johns Hopkins University School of Medicine. She is also an attending physician at Kennedy Krieger Institute. Hilary Vernon has expertise in treating inborn errors of metabolism and mitochondrial disorders. She is the director of the Mitochondrial Care Center at The Johns Hopkins Hospital and the Barth Syndrome Interdisciplinary Clinic at the Kennedy Krieger Institute. Her research interests include understanding intermediary metabolism in Barth syndrome and in disorders of branch chain amino acid metabolism. Dr. Vernon also co-directs the Department of Genetic Medicine Clinical Trials Unit, and is the principal investigator on multiple clinical trials for rare diseases. Dr. Vernon received her medical degree and doctorate from Rutgers University, New Brunswick, New Jersey. She completed residencies in genetics and pediatrics at The Johns Hopkins University, and a fellowship in clinical laboratory biochemical genetics at The Johns Hopkins University. Dr. Vernon was recognized with the 2010 Francis F. Schwentker Award for Excellence in Research at Johns Hopkins University and the 2011 James B. Sidbury Jr. Fellowship in Biochemical Genetics at Johns Hopkins University. Dr. Vernon is rated as a Distinguished provider by MediFind in the treatment of Ornithine Transcarbamylase Deficiency. Her top areas of expertise are Methylmalonic Acidemia, Propionic Acidemia, Infantile Neutropenia, Progressive External Ophthalmoplegia, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cushing's diseaseDr. Stratakis isElite. Learn about Cushing's disease.
- Gastrointestinal Stromal TumorDr. Stratakis isElite. Learn about Gastrointestinal Stromal Tumor.
- Neuroendocrine TumorDr. Stratakis isElite. Learn about Neuroendocrine Tumor.
- Distinguished
- Acromegaloid Facial Appearance SyndromeDr. Stratakis isDistinguished. Learn about Acromegaloid Facial Appearance Syndrome.
- Hypertrichosis-Acromegaloid Facial Appearance Syndrome
- IntersexDr. Stratakis isDistinguished. Learn about Intersex.
- Peutz-Jeghers SyndromeDr. Stratakis isDistinguished. Learn about Peutz-Jeghers Syndrome.
- Advanced
- Li-Fraumeni SyndromeDr. Stratakis isAdvanced. Learn about Li-Fraumeni Syndrome.
- MosaicismDr. Stratakis isAdvanced. Learn about Mosaicism.
- NeurofibromatosisDr. Stratakis isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Stratakis isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- ObesityDr. Stratakis isAdvanced. Learn about Obesity.
- Ornithine Transcarbamylase DeficiencyDr. Stratakis isAdvanced. Learn about Ornithine Transcarbamylase Deficiency.
- Experienced
- AnemiaDr. Stratakis isExperienced. Learn about Anemia.
- Aplasia Cutis CongenitaDr. Stratakis isExperienced. Learn about Aplasia Cutis Congenita.
- Beckwith-Wiedemann SyndromeDr. Stratakis isExperienced. Learn about Beckwith-Wiedemann Syndrome.
- Clouston SyndromeDr. Stratakis isExperienced. Learn about Clouston Syndrome.
- Cortical DysplasiaDr. Stratakis isExperienced. Learn about Cortical Dysplasia.
- Ectodermal DysplasiasDr. Stratakis isExperienced. Learn about Ectodermal Dysplasias.

